Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 4.88 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Entasis Therapeutics Holdings Inc | ETTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.08 | 1.67% | 4.88 | 4.92 | 4.70 | 4.92 | 4.80 | 18:02:11 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 3.75 | 6.60 | 2.85 | 43.18% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 47 | 8,240 | $ 4.88 | $ 40,222 | 13,334 | 4.24 - 9.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:19:56 | formt | 222 | $ 4.88 | USD |
Entasis Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 64.86M | 13.29M | $ -32.95M | 78.69 | - | 13.27M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 1.00 | 0.20% |
Entasis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ETTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.9183 | 4.92 | 4.24 | 4.77 | 7,520 | -0.0383 | -0.78% |
| 1 Month | 5.0828 | 5.4361 | 4.24 | 4.94 | 12,121 | -0.2028 | -3.99% |
| 3 Months | 6.0622 | 6.28 | 4.24 | 5.08 | 11,030 | -1.18 | -19.5% |
| 6 Months | 6.35 | 9.25 | 4.24 | 6.04 | 14,335 | -1.47 | -23.15% |
| 1 Year | 5.58 | 9.25 | 4.24 | 6.17 | 12,056 | -0.70 | -12.54% |
| 3 Years | 13.45 | 13.70 | 3.9703 | 7.71 | 30,145 | -8.57 | -63.72% |
| 5 Years | 13.45 | 13.70 | 3.9703 | 7.71 | 30,145 | -8.57 | -63.72% |
Entasis Therapeutics Description
| Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. It has the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes etx2514sul, zoliflodacin, etx0282cpdp, and nbp program. |
